Evidence map›Paper›PMID 42001116›Full record

ReviewJournal of nanobiotechnology2026

Microenvironment engineering with injectable hydrogel-based biofunctional scaffolds for augmenting bone defect regeneration.

Yilong Dong, Yang Fei, Yan Hu, Chunyuan Cai, Menghuan Li, Zhong Luo

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yilong Dong *Ruian People's Hospital, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325200, China.
Yang Fei *School of Life Sciences, Chongqing University, Chongqing, 400044, China.
Yan HuCollege of Bioengineering, Chongqing University, Chongqing, 400044, China.
Chunyuan CaiRuian People's Hospital, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325200, China. chunyuancai@wmu.edu.cn.
Menghuan LiSchool of Life Sciences, Chongqing University, Chongqing, 400044, China. menghuanli@cqu.edu.cn.
Zhong LuoSchool of Life Sciences, Chongqing University, Chongqing, 400044, China. luozhong918@cqu.edu.cn.

Funding

Health Commission of Zhejiang Province 2024KY398Ministry of Science and Technology of the People's Republic of China 2022YFB3804400National Natural Science Foundation of China 52333011National Natural Science Foundation of China 52471261Wenzhou Municipal Science and Technology Bureau Y2023458
6 · The paper itself

Abstract

Bone defects are common injuries in the clinic that often require the use of bone grafts to facilitate bone regeneration. However, the application of bone grafts is challenged by invasive surgeries, insufficient bone regeneration capability and limited availability, necessitating the development of substituting materials with enhanced safety, osteogenic capacity and large-scale applicability. Interestingly, injectable hydrogels emerge as a promising candidate for bone defect repair on account of their intrinsic biocompatibility, biomimetic structures, in-situ morphological malleability and versatile functionality. Herein, a comprehensive account is provided on the development of injectable hydrogel-based biomaterials and their application as scaffolds for supporting and guiding bone defect healing, focusing on the gelling mechanisms as well as their potential osteoinductive properties through (1) establishing osteoinductive microenvironment and (2) localized delivery of osteogenic therapeutics for boosting osteogenesis. Furthermore, existing challenges and potential breakthroughs in injectable hydrogel-based biofunctional scaffolds for bone defect treatment are discussed in-depth, focusing on the leveraging their therapeutic persistence and degradability, cost-effectiveness and dynamic material-biointeractions. It is anticipated that the insights in this review may provide new opportunities for minimally invasive bone defect treatment in the clinic.

Indexed as

Bone RegenerationHydrogelsTissue EngineeringTissue ScaffoldsAnimalsBiocompatible MaterialsBone and BonesHumansInjectionsOsteogenesisBiocompatible MaterialsHydrogelsBone defect healingBone microenvironment remodelingInjectable hydrogel scaffoldsLocalized drug delivery

Identifiers

PMID42001116
PMCPMC13227854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.